BAMCO Inc’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-414,122
Closed -$29.9M 359
2019
Q4
$29.9M Sell
414,122
-11,534
-3% -$833K 0.11% 142
2019
Q3
$59.7M Buy
425,656
+692
+0.2% +$97.1K 0.25% 94
2019
Q2
$77.8M Sell
424,964
-5,606
-1% -$1.03M 0.31% 75
2019
Q1
$68.5M Buy
430,570
+89,261
+26% +$14.2M 0.29% 84
2018
Q4
$32.7M Buy
341,309
+19,713
+6% +$1.89M 0.17% 128
2018
Q3
$45.4M Buy
321,596
+52,053
+19% +$7.35M 0.19% 120
2018
Q2
$42.2M Buy
269,543
+86,280
+47% +$13.5M 0.18% 122
2018
Q1
$29.5M Buy
183,263
+95,140
+108% +$15.3M 0.14% 146
2017
Q4
$14.5M Sell
88,123
-5,335
-6% -$879K 0.07% 190
2017
Q3
$5.82M Buy
93,458
+11,434
+14% +$712K 0.03% 220
2017
Q2
$6.53M Buy
82,024
+4,514
+6% +$359K 0.03% 214
2017
Q1
$5.51M Sell
77,510
-10,810
-12% -$768K 0.03% 219
2016
Q4
$4.51M Buy
88,320
+14,989
+20% +$765K 0.03% 214
2016
Q3
$3.38M Buy
73,331
+26,455
+56% +$1.22M 0.02% 227
2016
Q2
$1.41M Buy
46,876
+40,472
+632% +$1.22M 0.01% 254
2016
Q1
$205K Hold
6,404
﹤0.01% 283
2015
Q4
$373K Sell
6,404
-7,096
-53% -$413K ﹤0.01% 292
2015
Q3
$571K Buy
13,500
+6,000
+80% +$254K ﹤0.01% 325
2015
Q2
$547K Buy
+7,500
New +$547K ﹤0.01% 341